Biotech Commit Biologics appoints leading industry experts to newly formed Scientific Advisory Board June 4, 2025
Biotech PharmaMar presents at ASCO that the Zepzelca®(lurbinectedin) and atezolizumab (Tecentriq®) combination significantly improves survival as first-line maintenance therapy for extensive-stage small cell lung cancer June 3, 2025
Biotech Theravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million June 2, 2025
Biotech Breakthrough Clinical Data for LBL-024 in First-Line Treatment of Advanced EP-NEC Unveiled at 2025 ASCO Oral Session June 1, 2025
Biotech Transcripta Bio collaborates with Microsoft Research to Advance AI-Driven Disease-Gene Discovery May 31, 2025
Biotech CirCode Biomed Announces FDA Clearance for IND Application of HM2002, the world’s first circular RNA drug being administrated in patients May 31, 2025
Biotech BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement (“APA”) May 30, 2025